INSIDERFilingvia Quantisnow
Amyris Inc. logo

Amyris (AMRS) director Mccann received 80,000 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

James F Mccann (director at Amyris Inc., AMRS) reported that they received 80,000 shares on Aug 22, 2022. After these transactions the filing shows 121,271 shares held directly.

Reporting person
Mccann James F
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Aug 22, 2022Grant or award (A)Common Stock1+80,000--121,271 direct

Holdings before and after

  • Common Stock: 41,271 to 121,271 direct

Footnotes from the filing

  1. 1. Represents a restricted stock unit award that vests as to 100% of the units on August 22, 2023.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Mccann report in this AMRS Form 4?

James F Mccann (director at Amyris Inc., AMRS) reported that they received 80,000 shares on Aug 22, 2022. After these transactions the filing shows 121,271 shares held directly.

How many AMRS shares does Mccann hold after this filing?

The filing shows 121,271 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for AMRS

Earlier insider filings at AMRS

Quantisnow market dataNASDAQ
Amyris Inc. logo
AMRS
Amyris Inc.
Market cap
30-day
Sector
Industrials
Industry
Major Chemicals
Listed since
2010
Get push alerts for AMRS

Follow AMRS and get a push notification the moment its next story breaks.

Full AMRS profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMRS (Amyris Inc.) and more on Quantisnow.